Palepu Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 7.70 Cr
as on 29-10-2024
- Paid Up Capital ₹ 7.51 Cr
as on 29-10-2024
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 212.80 Cr
as on 29-10-2024
About Palepu Pharma Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.70 Cr and a paid-up capital of Rs 7.51 Cr.
The company currently has active open charges totaling ₹212.80 Cr.
Palepu Prasad, Palepu Gopal, and Gaurav Chaturvedi serve as directors at the Company.
- CIN/LLPIN
U24290TN2022PTC151110
- Company No.
151110
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Apr 2022
- Date of AGM
01 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Palepu Pharma Distributors?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Palepu Gopal  | Managing Director | 04-Apr-2022 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gaurav Chaturvedi | Additional Director | 05-Feb-2024 | Current |
| Palepu Prasad | Director | 04-Apr-2022 | Current |
Financial Performance and Corporate Structure Insights of Palepu Pharma Distributors.
Palepu Pharma Distributors Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Palepu Pharma Distributors?
In 2023, Palepu Pharma Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pleasant Foods Private LimitedActive 35 years 8 monthsPalepu Prasad and Palepu Gopal are mutual person
- Lph Pharma Private LimitedActive 28 years 11 months
Palepu Prasad and Palepu Gopal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Jun 2023 | ₹2.80 Cr | Open |
Hdfc Bank Limited Creation Date: 23 May 2023 | ₹210.00 Cr | Open |
How Many Employees Work at Palepu Pharma Distributors?
Palepu Pharma Distributors has a workforce of 164 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Palepu Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Palepu Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
